21185 ⎘
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies Veterinary vaccine
SINGLE DOMAIN ANTIBODIES THAT BIND AND NEUTRALIZE VENEZUELAN EQUINE ENCEPHALITIS VIRUS
#2VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE
#3METHOD FOR CONSTRUCTING CIRCULAR RNA AND VACCINE AGAINST FIPV
#4METHOD FOR CASTRATION OF ANIMALS
#5NINE-COMPONENT ANTIGEN AFRICAN SWINE FEVER SUBUNIT VACCINE
#6SEVEN-COMPONENT ANTIGEN AFRICAN SWINE FEVER SUBUNIT VACCINE
#7ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS
#8ANTI-IL31 ANTIBODIES FOR VETERINARY USE
#9VETERINARY PRODUCT
#10NUCLEIC ACID VACCINES ENCAPSULATED WITH NANOALUMINOSILICATE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV)
#11Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#12VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND NGF ANTIGENS
#13GRAM-NEGATIVE BACTERIA FOR USE IN THE PREVENTION AND TREATMENT OF DISEASE IN POULTRY
#14METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE
#15METHOD OF ADMINISTRATION OF AQUACULTURE VACCINES
#16BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES
#17SYSTEMS AND METHODS FOR PRODUCING ANTIBODIES
#18COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS
#19METHODS OF VACCINATING PIGS AGAINST PSEUDORABIES VIRUS
#20Composition and Methods for Treating Acute Diarrhea and Enteric Infections in Animals
#21Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens
#22CULTURE METHOD FOR FISH CELLS AND CELL CULTURE MEDIUM USED THEREIN, AND ORAL VACCINE FOR FISH
#23RATIONALLY DESIGNED MYCOPLASMA GALLISEPTICUM SUBUNIT VACCINE
#24EPSILON TOXIN FROM CLOSTRIDIUM PERFRINGENS AS A VACCINE
#25RECOMBINANT VECTOR FOR EXPRESSING IMMUNOGENIC PROTEIN OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV), RECOMBINANT STRAIN INCLUDING THE SAME, AND USE THEREOF
#26VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE
#27VACCINE AGAINST CAMPYLOBACTER JEJUNI
#28IMMUNOGENIC GEL COMPOSITIONS
#29COMPOSITION COMPRISING DRY EXTRACT OF LYOPHILISED INTESTINAL CONTENT OF ADULT CHICKEN, RELATIVE USE AS FOOD SUPPLEMENT AND USE FOR STIMULATING THE IMMUNE SYSTEM
#30NEW MULTIVALENT HVT VECTOR VACCINE
#31RECOMBINANT FLAVOBACTERIUM COVAE PROTEIN VACCINES
#32METHODS OF MANUFACTURING PORCINE ENDOGENOUS RETROVIRUS (PERV) FREE ANIMAL HEALTH VACCINES
#33PORCINE ENDOGENOUS RETROVIRUS (PERV)-FREE PORCINE CIRCOVIRUS TYPE 2D-BASED VACCINES AND METHODS OF USE
#34PEPTIDE VACCINES AGAINST INTERLEUKIN-31
#35ORAL VACCINE COMPOSITION
#36BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#37VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#38Cancer Vaccines and Methods of Treatment Using The Same
#39Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use
#40VACCINES AGAINST MORITELLA VISCOSA
#41IgY Antibody Compositions and Methods for Treating Avian Species
#42Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#43VACCINE AGAINST INFECTIOUS BRONCHITIS
#44RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC)
#45SINGLE VIAL VACCINE FORMULATIONS
#46AVIAN INFLUENZA VIRUS VACCINES
#47mRNA vaccine for porcine Deltacoronavirus, preparation method and application thereof
#48A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION
#49VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND FELINE IL-1 BETA MUTEIN ANTIGENS
#50VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND CANINE IL-1 BETA MUTEIN ANTIGENS
#51VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND IL-1 BETA MUTEIN ANTIGENS
#52ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS
#53TREATMENT OF PRURITUS IN HORSES
#54RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA
#55VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#56MULTIVALENT ANTI-CAMPYLOBACTER ANTIBODIES AND VACCINE
#57METHODS FOR PREDICTING EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) VACCINE
#58Anti-P53 Antibodies
#59VETERINARY VACCINES AND METHODS FOR THE TREATMENT OF PASTEURELLA MULTOCIDA INFECTIONS IN FOOD PRODUCTION ANIMALS
#60VACCINE
#61VETERINARY VACCINES AND METHODS FOR THE TREATMENT OF PASTEURELLA MULTOCIDA INFECTIONS IN FOOD PRODUCTION ANIMALS
#62PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING PASTEURELLA PROTEINS AND METHODS OF USE
#63NEW FELINE HERPES VIRUS VACCINE
#64FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#65LIVE MYCOPLASMA GALLISEPTICUM VACCINES
#66RECOMBINANT CLASSICAL SWINE FEVER VIRUS E2 PROTEIN WITH B/C DOMAIN SWAPPING
#67IDENTIFICATION OF G. PARASUIS IMMUNOGENIC PROTEINS AND SUBUNIT VACCINE COMPRISING SUCH
#68COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS
#69POLYVALENT VACCINES FOR STAPHYLOCOCCAL & STREPTOCOCCAL INFECTION
#70PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS
#71Modulation of Interleukin 17F for Treatment of Infection and Organ Dysfunction
#72ATTENUATED BORDETELLA BRONCHISEPTICA STRAINS, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS, AND METHODS OF MAKING & USE THEREOF
#73COMPOSITIONS OF VACCINES AGAINST CLOSTRIDIAL DERMATITIS AND METHODS OF USE THEREOF
#74SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS
#75CELL-BASED VACCINES
#76LIVE MYCOPLASMA SYNOVIAE VACCINE
#77POLYMERSOMES COMPRISING A SOLUBLE ENCAPSULATED ANTIGEN AS WELL AS METHODS OF MAKING AND USES THEREOF
#78PREPARATION OF LIVE VACCINES
#79METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#80ANAPLASMA VACCINES AND METHODS OF USE THEREOF
#81IN OVO VACCINE COMPOSITIONS AGAINST COCCIDIOSIS
#82AFRICAN SWINE FEVER VACCINE COMPOSITION
#83COMBINATION, COMPOSITION, AND METHOD OF ADMINISTERING THE COMBINATION OR COMPOSITION TO ANIMALS
#84METHOD OF IMPROVING THE CONSISTENCY AND/OR QUALITY OF A FELINE ANTIBODY
#85DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA
#86VIRAL VECTOR DELIVERY SYSTEM FOR BOTH RESPIRATORY AND DIGESTIVE TRACTS OF PIGS AND APPLICATION THEREOF
#87DNA VACCINE AGAINST LEISHMANIASIS
#88METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE
#89PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS
#90COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS
#91VACCINE FOR EQUINE HERPESVIRUS
#92OIL-BASED ADJUVANTS
#93CLOSTRIDIUM CHAUVOEI VACCINE AND METHOD OF MAKING
#94A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis
#95EXPRESSION OF EIMERIA SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME
#96ACTIVE IMMUNIZATION FOR REDUCING OSTEOARTHRITIC, NEUROPATHIC, AND CANCER PAIN
#97A MURINE CYTOMEGALOVIRUS VACCINE VECTOR FOR ADMINISTRATION IN A NON-MOUSE SUBJECT
#98INFLUENZA VIRUS MUTANTS AND USES THEREFOR
#99PORCINE CORONAVIRUS VACCINES
#100VIRAL VECTORED VACCINES FOR SWINE INFLUENZA VIRUS AND METHODS OF USE
#101USE OF CODON DEOPTIMISATION AND OPTIMISATION TO PRODUCE A LARYNGOTRACHEITIS VIRUS-ATTENUATED VACCINE
#102PORCINE EPIDEMIC DIARRHEA VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM
#103IBV VACCINE WITH HETEROLOGOUS DMV/1639 SPIKE PROTEIN
#104HVT AIV VECTORS AND USES THEREOF
#105USE OF INTERFERON AS AN ADJUVANT IN VACCINES
#106FOWL ADENOVIRUS SUBUNIT VACCINE AND PRODUCTION METHOD THEREOF
#107IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF
#108COMPOSITIONS AND METHODS FOR EXPRESSING ANTIGENS ON CELL MEMBRANE
#109VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES
#110EXPRESSION OF BORRELIA BURGDORFERI OUTER SURFACE PROTEIN A IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME
#111ENCAPSULATED LIQUID PRODUCT AND PROCESS FOR ENCAPSULATING HYDROPHILIC MATERIAL
#112OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS
#113LYME DISEASE RNA VACCINE
#114A METHOD TO PRODUCE A VACCINE AGAINST STREPTOCOCCUS SUIS AND THE SAID VACCINE
#115EXPRESSION OF EIMERIA SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME
#116IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
#117MULTIVALENT VACCINE COMPOSITION FOR PREVENTION OF PORCINE MYCOPLASMA AND PORCINE CIRCOVIRUS INFECTIONS
#118ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF
#119FELINE LEUKEMIA VIRUS VACCINE
#120NEMATODE VACCINE
#121ATTENUATED ALPHAVIRUS
#122VACCINE INCLUDING NONENCAPSULATED STRAIN AS ANTIGEN
#123METHODS AND COMPOSITIONS FOR ORALLY DOSING ANIMALS
#124MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE
#125RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#126SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS
#127UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS
#128A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#129NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF
#130Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
#131Novel Adjuvant Compositions
#132IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR
#133VACCINE FOR PREVENTING AFRICAN SWINE FEVER, COMPRISING AFRICAN SWINE FEVER VIRUS-DERIVED ANTIGEN PROTEIN
#134LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES
#135VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME
#136A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#137A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES
#138TREATMENT OF URTICARIA
#139MICROENCAPSULATED STERNE VACCINE
#140BOVINE COLOSTRUM DERIVED ANTIBODIES AND USES THEREOF
#141PORCINE BIVALENT SUBUNIT VACCINE COMPOSITION IN A SINGLE DOSE
#142VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION
#143VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES
#144Attenuated Porcine Epidemic Diarrhea Virus
#145RABIES VIRUS VACCINE
#146Toothpaste for Delivery of Allergens to Oral Mucosa
#147RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF
#148Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
#149Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#150Cattle fever tick-infestation vaccines and uses thereof
#151PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING KLEBSIELLA PROTEINS AND METHODS OF USE
#152Foot-and-mouth disease vaccine
#153A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE 9, SEQUENCE TYPE 16
#154SALMONELLA VACCINE
#155PSEUDORABIES VIRUS VACCINE
#156EXTENDED-RANGE SPRAY APPLICATOR
#157VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAME
#158PREPARATION OF LIVE VACCINES
#159CANINE LYME DISEASE VACCINE
#160CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION
#161METHODS, DEVICE, KIT AND COMPOSITIONS FOR DETECTING FELINE LUNGWORM
#162HORN FLY VACCINE COMPOSITIONS AND METHODS OF MAKING SAME
#163METHODS AND COMPOSITIONS FOR DETECTING AND PRODUCING PORCINE MORBILLIVIRUS AND VACCINES THEREOF
#164CATTLE FEVER TICK-INFESTATION VACCINES AND USES THEREOF
#165Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens
#166Attenuating bacterial virulence by attenuating bacterial folate transport
#167CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS
#168OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS
#169ANTI-IL31 ANTIBODIES FOR VETERINARY USE
#170Universal influenza vaccine
#171BOVINE HERPESVIRUS TYPE 1 (BoHV-1) QUADRUPLE GENE DELETED MUTANT
#172MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
#173Cancer Vaccines and Methods of Treatment Using The Same
#174LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME
#175METHODS AND DEVICES FOR MEDICAMENT DELIVERY
#176OPTIMIZED POLYPEPTIDE FOR A SUBUNIT VACCINE AGAINST AVIAN REOVIRUS
#177REDUCED FOAMING VACCINE COMPOSITIONS
#178() vaccine
#179CONJUGATED ZEARALENONE TO PROTECT AGAINST MYCOTOXICOSIS
#180M Hyo Multivalent Vaccine and Uses Thereof
#181POULTRY DRINKING WATER-BASED VACCINE DELIVERY SYSTEM AND METHOD
#182CONJUGATED T-2 TOXIN TO PROTECT AGAINST MYCOTOXICOSIS
#183RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA
#184COMBINATION VACCINE FOR PROTECTING SWINE AGAINST VARIOUS DISORDERS
#185COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS
#186THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE
#187FOAM VACCINATION OF AVIANS
#188Oil-based adjuvants
#189Proteins and immunizing compositions containing proteins and methods of use
#190Biomarkers and immunogenic compositions for filarial parasites
#191COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN
#192METHOD OF SUPPRESSING IMMUNE RESPONSE TO VECTOR-DELIVERED THERAPEUTIC PROTEIN
#193Vaccine for protection against
#194UNIVERSAL MAMMALIAN INFLUENZA VACCINE
#195ANTI-IL31 ANTIBODIES FOR VETERINARY USE
#196ENHANCED IMMUNOGENIC DNA/RNA COMPOSITIONS AND METHODS
#197A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG
#198CANINE CANCER VACCINE
#199METHOD TO CREATE PERSONALIZED CANINE CANCER VACCINES
#200Modified Marek's disease virus, and vaccines made therefrom
#201MULTIVALENT VACCINES AGAINST TURKEY ARTHRITIS REOVIRUS
#202Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
#203IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#204Canine parvovirus nanobody CPV-VHH-E3 and application thereof
#205SINGLE VIAL VACCINE FORMULATIONS
#206Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#207HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION
#208SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES
#209Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof
#210Southern cattle tick vaccine product
#211SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT HAVING A SPECIFIC ORDER OF GENES
#212Subunit Vaccine Composition For African Swine Fever, And Preparation Therefor And Use Thereof
#213Anti-p53 antibodies
#214Cocktail Vaccine of Recombinant African Swine Fever Virus (ASFV) Antigen and Use Thereof
#215ATTENUATED VARIANT OF THE RIFT VALLEY FEVER VIRUS, COMPOSITION COMPRISING SAME, AND USES THEREOF
#216RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS
#217TRANSMISSION-BLOCKING VACCINE AGAINST BABESIA
#218RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME
#219DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE O
#220TRANSFORMED PLANTS AND METHODS FOR MAKING AND USING THE SAME
#221A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE
#222Vaccine for prevention of necrotic enteritis in poultry
#223IMMUNOGENIC GEL COMPOSITIONS
#224Immunization of large mammals with low doses of RNA
#225Use of the Salmonella SPP Type III Secretion Proteins as a Protective Vaccination
#226METHODS AND COMPOSITIONS FOR VIRAL VECTORED GnRH VACCINES TO CONTROL REPRODUCTION AND BREEDING BEHAVIOR IN MAMMALS
#227Method to reduce tick population with a universal tick antigen
#228Immunisation of large mammals with low doses of RNA
#229Immunisation of large mammals with low doses of RNA
#230Immunisation of large mammals with low doses of RNA
#231Immunisation of large mammals with low doses of RNA
#232INACTIVATED PISCINE ORTHOREOVIRUS VACCINE
#233Vaccine and Methods for Detecting and Preventing Filariasis
#234Methods of vaccine administration
#235RECOMBINANT ANTIGEN AND METHOD OF MAKING THE SAME, ISOLATED POLYNUCLEOTIDE OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND IMMUNOGENIC COMPOSITION INCLUDING THE SAME
#236Single Domain Antibodies that Bind and Neutralize Venezuelan Equine Encephalitis Virus
#237MULTIVALENT HVT VECTOR VACCINE
#238CRYPTOSPORIDIOSIS VACCINE
#239Influenza virus mutants and uses therefor
#240Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#241VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
#242Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine
#243METHOD OF DETERMINING THE IDENTITY AND/OR AMOUNT OF AN ANTI-IL-31 ANTIBODY IN A SAMPLE
#244EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS
#245Treatment of insect bite hypersensitivity
#246BEE VACCINES AND METHODS OF USE
#247MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT AGAINST CANINE CD20
#248Vaccine delivery method
#249IMMUNOGENIC COMPOSITIONS
#250North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#251METHODS OF VACCINATION AND USE OF CD47 BLOCKADE
#252Artificial alphavirus-derived RNA replicon expression systems
#253Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
#254Universal influenza vaccine
#255Rabies vaccine
#256Hyperimmunized egg product for treatment or prevention of coronavirus infection
#257METHOD FOR VACCINATING AVIANS AGAINST REOVIRUS
#258Compositions and methods of enhancing immune responses to or limiting infection
#259FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#260Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein
#261Sea lice vaccine
#262METHODS FOR GROWING AFRICAN SWINE FEVER VIRUS IN FETAL PORCINE LUNG ALVEOLAR MACROPHAGE CELLS
#263Antibodies against microorganisms and uses thereof
#264FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#265COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR TREATMENT OF INFECTIONS AND CANCER AND OTHER ACUTE AND CHRONIC CONDITIONS OF THE EYE
#266SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM
#267DRUG DELIVERY COMPOSITION
#268ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF
#269REDUCED FOAMING VACCINE COMPOSITIONS
#270Porcine Reproductive and Respiratory Syndrome vaccine virus
#271Horn fly protein as active antigen in anti-horn fly vaccine for protection of bovines against horn fly infestations
#272VACCINE TO PROTECT A PIG AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE
#273Attenuating bacterial virulence by attenuating bacterial folate transport
#274VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY
#275Feline leukemia virus vaccine
#276ATTENUATED IBV WITH EXTENDED CELL CULTURE AND TISSUE TROPISM
#277INTRINSIC SYSTEM FOR VIRAL VECTOR TRANSGENE REGULATION
#278CSFV SUBUNIT VACCINE
#279African swine fever (ASF) virus vaccines
#280Vaccine against infectious bronchitis
#281Stabilisation of live mollicutes bacteria in a liquid composition
#282TREATMENT OF PRURITUS IN HORSES
#283TREATMENT OF A CANINE CD20 POSITIVE DISEASE OR CONDITION USING A CANINE CD20-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
#284FUSION PROTEIN USEFUL FOR VACCINATION AGAINST ROTAVIRUS
#285LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME
#286PORCINE EPIDEMIC DIARRHEA (PED) VIRUS VACCINE COMPOSITION AND PREPARATION METHOD THEREOF
#287Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses
#288Interleukin-31 monoclonal antibodies for veterinary use
#289Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
#290Paramyxovirus and uses thereof
#291Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus
#292PRODUCTION OF VIRUSES IN CONTINUOUSLY GROWING EPITHELIAL CELL LINES DERIVED FROM CHICKEN GUT
#293IMMUNOGENIC COMPOSITION FOR PORCINE EPIDEMIC DIARRHEA VIRUS
#294Materials and methods for respiratory disease control in canines
#295strains and vaccines having hyaC and nanP deletions
#296Attenuated isolate of infectious bronchitis virus strain DMV1639
#297Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens
#298Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
#299Foot-and-mouth disease vaccine
#300Preparation of live vaccines